Table 1.
Total | Untreated | Treated | p - value | |
---|---|---|---|---|
Patients | 574 | 287 | 287 | |
Age, yr; Mean (IQR) | 62,24 (61,2-63,2) | 62,78 (61,9-63,2) | 61,61 (61,2-62,6) | 0,2281 |
No Smokers | 158 | 77 | 81 | |
Smokers | 200 | 133 | 67 | 0,778 |
Former Smokers | 216 | 77 | 139 | |
Stage | 0,513 | |||
pTa | 284 | 153 | 131 | |
Cis | 17 | 8 | 9 | |
pT1 | 273 | 126 | 147 | |
Grade | 0,253 | |||
Low Grade | 206 | 119 | 87 | |
High Grade | 368 | 168 | 200 | |
Intravesical therapy | 0.07 | |||
BCG | 290 | 134 | 156 | |
MytomicinC | 284 | 153 | 131 | |
SUBGROUPS | Group A | Group B | Group C | p - value |
Patients | 98 | 91 | 98 | |
Age, yr; Mean (IQR) | 61,43 (61,2-62,8) | 61,31 (61,2-62,4) | 62,71 (61,9-63,3) | 0,639 |
IQR = Interquartile Range Group: A = Cardioaspirin; B = Statins; C = Association.